Skip to main content
PMC home page
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2007 Jan 25;53:i–S58. doi: 10.1016/S0163-4453(07)60001-2

Pandemic Flu

Clinical management of patients with an influenza-like illness during an influenza pandemic

British Infection Society, British Thoracic Society, Health Protection Agency in collaboration with the Department of Health
PMCID: PMC7133687  PMID: 17376371

The content is available as a PDF (950.9 KB).

References

  • 1.http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_5.pdf.
  • 2.http://www.dh.gov.uk/assetRoot/04/10/44/37/04104437.pdf.
  • 3.http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4121752&chk=lfHfV7.
  • 4.http://www.dh.gov.uk/assetRoot/04/11/10/82/04111082.pdf.
  • 5.http://www.dh.gov.uk/PublicationsAndStatistics/Publications/PublicationsPolicyAndGuidance/PublicationsPolicyAndGuidanceArticle/fs/en?CONTENT_ID=4119491&&chk=T/Iaww.
  • 6.Fleming DM, Elliott AJ, Nguyen-Van-Tam JS, Watson JM, Wise R. A Winter's Tale: coming to terms with winter respiratory illnesses. Health Protection Agency; London: 2005. [Google Scholar]
  • 7.Nguyen-Van-Tam JS, Hampson AW. The epidemiology and clinical impact of pandemic influenza. Vaccine. 2003;21(16):1762–1768. doi: 10.1016/s0264-410x(03)00069-0. [DOI] [PubMed] [Google Scholar]
  • 8.http://www.who.int/csr/disease/influenza/H5N19reduit.pdf.
  • 9.http://www.who.int/csr/resources/publications/influenza/WHO_CDS_CSR_GIP_2005_7_04.pdf.
  • 10.http://emc.medicines.org.uk/emc/industry/default.asp?page=displaydoc.asp&documentid=10446.
  • 11.Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health. 2000;3(1):32–38. [PubMed] [Google Scholar]
  • 12.Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178(1):53–60. doi: 10.1086/515616. [DOI] [PubMed] [Google Scholar]
  • 13.Cooper BS, Pitman RJ, Edmunds WJ, Gay NJ. Delaying the international spread of pandemic influenza. PLoS Med. 2006 Jun;3(6):e212. doi: 10.1371/journal.pmed.0030212. Epub 2006 May 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ. 1997;315(7115):1060–1064. doi: 10.1136/bmj.315.7115.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358(9291):1410–1416. doi: 10.1016/s0140-6736(01)06528-x. [DOI] [PubMed] [Google Scholar]
  • 16.Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc. 1992;40(2):115–119. doi: 10.1111/j.1532-5415.1992.tb01929.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Call SA, Vollenweider MA, Hornung CA, Simel DL, McKinney WP. Does this patient have influenza? JAMA. 2005;293(8):987–997. doi: 10.1001/jama.293.8.987. [DOI] [PubMed] [Google Scholar]
  • 18.Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160(21):3243–3247. doi: 10.1001/archinte.160.21.3243. [DOI] [PubMed] [Google Scholar]
  • 19.Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis. 2000;31(5):1166–1169. doi: 10.1086/317425. [DOI] [PubMed] [Google Scholar]
  • 20.Govaert TM, Dinant GJ, Aretz K, Knottnerus JA. The predictive value of influenza symptomatology in elderly people. Fam Pract. 1998;15(1):16–22. doi: 10.1093/fampra/15.1.16. [DOI] [PubMed] [Google Scholar]
  • 21.Monto AS, Webster A, Keene O. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis. J Antimicrob Chemother. 1999;44(Suppl B):23–29. doi: 10.1093/jac/44.suppl_2.23. [DOI] [PubMed] [Google Scholar]
  • 22.Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med. 1997;337(13):874–880. doi: 10.1056/NEJM199709253371302. [DOI] [PubMed] [Google Scholar]
  • 23.Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA. 2000;283(8):1016–1024. doi: 10.1001/jama.283.8.1016. [DOI] [PubMed] [Google Scholar]
  • 24.Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87(12):1944–1950. doi: 10.2105/ajph.87.12.1944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Nicholson KG. Human influenza. In: Nicholson K, Webster R, Hay A, editors. Textbook of Influenza. 2nd ed. Blackwell; Oxford: 2000. [Google Scholar]
  • 26.Potter CW. Influenza. In: Zuckerman AJ, Banatvala JE, Pattison JR, Griffiths PD, Schoub B, editors. Principles and Practice of Clinical Virology. 5th edn. Wiley; Chicester: 2004. p. 280. ch. 5. [Google Scholar]
  • 27.Kilbourne E. Influenza. 1st ed. Plenum Publishing; New York: 1987. [Google Scholar]
  • 28.Cox NJ, Subbarao K. Influenza. Lancet. 1999;354(9186):1277–1282. doi: 10.1016/S0140-6736(99)01241-6. [DOI] [PubMed] [Google Scholar]
  • 29.Nicholson KG. Clinical features of influenza. Semin Respir Infect. 1992;7(1):26–37. [PubMed] [Google Scholar]
  • 30.Woodall J, Rowson KE, McDonald JC. Age and Asian influenza, 1957. Br Med J. 1958;5108:1316–1318. doi: 10.1136/bmj.2.5108.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Bogart DB, Liu C, Ruth WE, Kerby GR, Williams CH. Rapid diagnosis of primary influenza pneumonia. Chest. 1975;68(4):513–517. doi: 10.1378/chest.68.4.513. [DOI] [PubMed] [Google Scholar]
  • 32.Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet. 1958;2(7040):233–236. doi: 10.1016/s0140-6736(58)90060-6. [DOI] [PubMed] [Google Scholar]
  • 33.Nicholson KG. Should staff in long-stay hospitals for elderly patients be vaccinated against influenza? Lancet. 2000;355(9198):83–84. doi: 10.1016/S0140-6736(99)00310-4. [DOI] [PubMed] [Google Scholar]
  • 34.Schwarzmann SW, Adler JL, Sullivan RJ, Jr., Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968 1969. Arch Intern Med. 1971;127(6):1037–1041. [PubMed] [Google Scholar]
  • 35.Ruben FL, Cate TR. Influenza pneumonia. Semin Respir Infect. 1987;2(2):122–129. [PubMed] [Google Scholar]
  • 36.Jarstrand C, Tunevall G. The influence of bacterial superinfection on the clinical course of influenza. Studies from the influenza epidemics in Stockholm during the winters 1969 70 and 1971 72. Scand J Infect Dis. 1975;7(4):243–247. doi: 10.3109/inf.1975.7.issue-4.04. [DOI] [PubMed] [Google Scholar]
  • 37.Oswald NC, Shooter RA, Curwen MP. Pneumonia complicating Asian influenza. Br Med J. 1958;5108:1305–1311. doi: 10.1136/bmj.2.5108.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Vilchez RA, Fung JJ, Kusne S. Influenza A myocarditis developing in an adult liver transplant recipient despite vaccination: a case report and review of the literature. Transplantation. 2000;70(3):543–545. doi: 10.1097/00007890-200008150-00026. [DOI] [PubMed] [Google Scholar]
  • 39.McGregor D, Henderson S. Myocarditis, rhabdomyolysis and myoglobinuric renal failure complicating influenza in a young adult. NZ Med J. 1997;110(1046):237. [PubMed] [Google Scholar]
  • 40.Kessler HA, Trenholme GM, Harris AA, Levin S. Acute myopathy associated with influenza A/Texas/1/77 infection. Isolation of virus from a muscle biopsy specimen. JAMA. 1980;243(5):461–462. [PubMed] [Google Scholar]
  • 41.Yoshino M, Suzuki S, Adachi K, Fukayama M, Inamatsu T. High incidence of acute myositis with type A influenza virus infection in the elderly. Intern Med. 2000;39(5):431–432. doi: 10.2169/internalmedicine.39.431. [DOI] [PubMed] [Google Scholar]
  • 42.Zamkoff K, Rosen N. Influenza and myoglobinuria in brothers. Neurology. 1979;29(3):340–345. doi: 10.1212/wnl.29.3.340. [DOI] [PubMed] [Google Scholar]
  • 43.Minow RA, Gorbach S, Johnson BL, Jr., Dornfeld L. Myoglobinuria associated with influenza A infection. Ann Intern Med. 1974;80(3):359–361. doi: 10.7326/0003-4819-80-3-359. [DOI] [PubMed] [Google Scholar]
  • 44.Hakoda S, Nakatani T. A pregnant woman with influenza A encephalopathy in whom influenza A/Hong Kong virus (H3) was isolated from cerebrospinal fluid. Arch Intern Med. 2000;160(7):1041–1045. doi: 10.1001/archinte.160.7.1041. [DOI] [PubMed] [Google Scholar]
  • 45.Mihara M, Utsugisawa K, Konno S, Tohgi H. Isolated lesions limited to the bilateral substantia nigra on MRI associated with influenza A infection. Eur Neurol. 2001;45(4):290–291. doi: 10.1159/000052149. [DOI] [PubMed] [Google Scholar]
  • 46.Studahl M. Influenza virus and CNS manifestations. J Clin Virol. 2003;28(3):225–232. doi: 10.1016/s1386-6532(03)00119-7. [DOI] [PubMed] [Google Scholar]
  • 47.Jacobs BC, Rothbarth PH, van der Meche FG, Herbrink P, Schmitz PI, de Klerk MA. The spectrum of antecedent infections in Guillain-Barre syndrome: a case-control study. Neurology. 1998;51(4):1110–1115. doi: 10.1212/wnl.51.4.1110. [DOI] [PubMed] [Google Scholar]
  • 48.Salonen O, Koshkiniemi M, Saari A, Myllyla V, Pyhala R, Airaksinen L. Myelitis associated with influenza A virus infection. J Neurovirol. 1997;3(1):83–85. doi: 10.3109/13550289709015797. [DOI] [PubMed] [Google Scholar]
  • 49.Sion ML, Hatzitolios AI, Toulis EN, Mikoudi KD, Ziakas GN. Toxic shock syndrome complicating influenza A infection: a two-case report with one case of bacteremia and endocarditis. Intensive Care Med. 2001;27(2):443. doi: 10.1007/s001340000803. [DOI] [PubMed] [Google Scholar]
  • 50.Sharkey R, Mulloy E. Taxic shock syndrome following influenza A infection. Intensive Care Med. 1999;25(3):335–336. doi: 10.1007/pl00022673. [DOI] [PubMed] [Google Scholar]
  • 51.Brill SJ, Gilfillan RF. Acute parotitis associated with influenza type A: a report of twelve cases. N Engl J Med. 1977;296(24):1391–1392. doi: 10.1056/NEJM197706162962408. [DOI] [PubMed] [Google Scholar]
  • 52.WHO. Document WHO/CDS/2005.29, Avian influenza: assessing the pandemic threat. WHO; Jan 2005.
  • 53.Apisarnthanarak A, Kitphati R, Thongphubeth K, Patoomanunt P, Anthanont P, Auwanit W. Atypical avian influenza (H5N1) Emerg Infect Dis. 2004;10(7):1321–1324. doi: 10.3201/eid1007.040415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005;352(7):686–691. doi: 10.1056/NEJMoa044307. [DOI] [PubMed] [Google Scholar]
  • 55.Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353(13):1374–1385. doi: 10.1056/NEJMra052211. [DOI] [PubMed] [Google Scholar]
  • 56.Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, Chunsuthiwat S, Sawanpanyalert P, Kijphati R. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis. 2005;11(2):201–209. doi: 10.3201/eid1102.041061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Grose C, Chokephaibulkit K. Avian influenza virus infection of children in Vietnam and Thailand. Pediatr Infect Dis J. 2004;23(8):793–794. doi: 10.1097/00006454-200408000-00024. [DOI] [PubMed] [Google Scholar]
  • 58.Harnden A, Brueggemann A, Perera R, Mayon-White R, Crook D, Thomson A, et al. Prospective study of the viral aetiology and clinical course among children in the community with cough and fever. 2005; submitted for publication.
  • 59.Maltezou HC, Drancourt M. Nosocomial influenza in children. J Hosp Infect. 2003;55(2):83–91. doi: 10.1016/s0195-6701(03)00262-7. [DOI] [PubMed] [Google Scholar]
  • 60.Munoz FM, Demmler GJ, Glezen WP. Influenza in children in Houston, Texas. Pediatr Res. 2005;47:272A. [Google Scholar]
  • 61.van Zeijl JH, Mullaart RA, Borm GF, Galama JM. Recurrence of febrile seizures in the respiratory season is associated with influenza A. J Pediatr. 2004;145(6):800–805. doi: 10.1016/j.jpeds.2004.08.075. [DOI] [PubMed] [Google Scholar]
  • 62.Peltola V, Ziegler T, Ruuskanen O. Influenza A and B virus infections in children. Clin Infect Dis. 2003;36(3):299–305. doi: 10.1086/345909. [DOI] [PubMed] [Google Scholar]
  • 63.Weir E. Influenza in children. CMAJ. 2003;169(10):1052. [PMC free article] [PubMed] [Google Scholar]
  • 64.Friedman MJ, Attia MW. Clinical predictors of influenza in children. Arch Pediatr Adolesc Med. 2004;158(4):391–394. doi: 10.1001/archpedi.158.4.391. [DOI] [PubMed] [Google Scholar]
  • 65.Hu JJ, Kao CL, Lee PI, Chen CM, Lee CY, Lu CY. Clinical features of influenza A and B in children and association with myositis. J Microbiol Immunol Infect. 2004;37(2):95–98. [PubMed] [Google Scholar]
  • 66.Neuzil KM, Wright PF, Mitchel EF, Jr., Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr. 2000;137(6):856–864. doi: 10.1067/mpd.2000.110445. [DOI] [PubMed] [Google Scholar]
  • 67.Stark ZL, Buttery JP, Antolovich GC, Reddihough DS. The impact of influenza A on children with disabilities. J Paediatr Child Health. 2004;40(5–6):332. doi: 10.1111/j.1440-1754.2004.00388.x. [DOI] [PubMed] [Google Scholar]
  • 68.Munoz FM. The impact of influenza in children. Semin Pediatr Infect Dis. 2002;13(2):72–78. doi: 10.1053/spid.2002.122992. [DOI] [PubMed] [Google Scholar]
  • 69.O'Brien Schwartz B. Severe pneumococcal pneumonia in previously healthy children: the role of preceding influenza infection. Clin Infect Dis. 2000;30(5):784–789. doi: 10.1086/313772. [DOI] [PubMed] [Google Scholar]
  • 70.Bonner AB, Monroe KW, Talley LI, Klasner AE, Kimberlin DW. Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics. 2003;112(2):363–367. doi: 10.1542/peds.112.2.363. [DOI] [PubMed] [Google Scholar]
  • 71.Chang LY, Huang FY, Wu F, Su IJ, Chiu NC, Chen KT. Childhood severe acute respiratory syndrome in Taiwan and how to differentiate it from childhood influenza infection. Arch Pediatr Adolesc Med. 2004;158(11):1037–1042. doi: 10.1001/archpedi.158.11.1037. [DOI] [PubMed] [Google Scholar]
  • 72.http://www.brit-thoracic.org.uk/iqs/bts_guidelines_pneumonia_html.
  • 73.Peltola V, Heikkinen T, Ruuskanen O. Clinical courses of croup caused by influenza and parainfluenza viruses. Pediatr Infect Dis J. 2002;21(1):76–78. doi: 10.1097/00006454-200201000-00020. [DOI] [PubMed] [Google Scholar]
  • 74.Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 1999;340(4):260–264. doi: 10.1056/NEJM199901283400402. [DOI] [PubMed] [Google Scholar]
  • 75.Munoz FM. Influenza virus infection in infancy and early childhood. Paediatr Respir Rev. 2003;4(2):99–104. [PubMed] [Google Scholar]
  • 76.http://www.hpa.org.uk/infections/topics_az/rsv/menu.htm.
  • 77.Garofalo RP, Hintz KH, Hill V, Patti J, Ogra PL, Welliver RC., Sr. A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus. J Med Virol. 2005;75(2):282–289. doi: 10.1002/jmv.20268. [DOI] [PubMed] [Google Scholar]
  • 78.Smidt MH, Stroink H, Bruinenberg JF, Peeters M. Encephalopathy associated with influenza A. Eur J Paediatr Neurol. 2004;8(5):257–260. doi: 10.1016/j.ejpn.2004.06.002. [DOI] [PubMed] [Google Scholar]
  • 79.Okabe N, Yamashita K, Taniguchi K, Inouye S. Influenza surveillance system of Japan and acute encephalitis and encephalopathy in the influenza season. Pediatr Int. 2000;42(2):187–191. doi: 10.1046/j.1442-200x.2000.01206.x. [DOI] [PubMed] [Google Scholar]
  • 80.Glasgow JFT, Hall SM, Rainsford KD, editors. Aspirin and related drugs. Taylor and Francis; London/New York: 2004. [Google Scholar]
  • 81.Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Rey's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999;340(18):1377–1382. doi: 10.1056/NEJM199905063401801. [DOI] [PubMed] [Google Scholar]
  • 82.Grose C. The puzzling picture of acute necrotizing encephalopathy after influenza A and B virus infection in young children. Pediatr Infect Dis J. 2004;23(3):253–254. doi: 10.1097/01.inf.0000114901.70040.33. [DOI] [PubMed] [Google Scholar]
  • 83.Huang SM, Chen CC, Chiu PC, Cheng MF, Lai PH, Hsieh KS. Acute necrotizing encephalopathy of childhood associated with influenza type B virus infection in a 3-year-old girl. J Child Neurol. 2004;19(1):64–67. doi: 10.1177/08830738040190010709. [DOI] [PubMed] [Google Scholar]
  • 84.Wang YH, Huang YC, Chang LY, Kao HT, Lin PY, Huang CG. Clinical characteristics of children with influenza A virus infection requiring hospitalization. J Microbiol Immunol Infect. 2003;36(2):111–116. [PubMed] [Google Scholar]
  • 85.Cartwright KA, Jones DM, Smith AJ, Stuart JM, Kaczmarski EB, Palmer SR. Influenza A and meningococcal disease. Lancet. 1991;338(8766):554–557. doi: 10.1016/0140-6736(91)91112-8. [DOI] [PubMed] [Google Scholar]
  • 86.Department of Health Influenza pandemic contingency planning: Operational Guidance on the provision of healthcare in a community setting in England. http://www.dh.gov.uk/assetRoot/04/13/77/96/04137796.pdf (accessed 15 Nov 2006).
  • 87.Sullivan PS, Hanson DL, Dworkin MS, Jones JL, Ward JW. Effect of influenza vaccination on disease progression among HIV-infected persons. AIDS. 2000;14(17):2781–2785. doi: 10.1097/00002030-200012010-00018. [DOI] [PubMed] [Google Scholar]
  • 88.www.nice.oeg.uk/CG012niceguideline
  • 89.Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I, Egurrola M. Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J. 2006;27(1):151–157. doi: 10.1183/09031936.06.00062505. [DOI] [PubMed] [Google Scholar]
  • 90.Ewig S, Torres A, Woodhead M. Assessment of pneumonia severity: a European perspective. Eur Respir J. 2006;27(1):6–8. doi: 10.1183/09031936.06.00130205. [DOI] [PubMed] [Google Scholar]
  • 91.Little P, Rumsby K, Kelly J, Watson L, Moore M, Warner G. Information leaflet and antibiotic prescribing strategies for acute lower respiratory tract infection: a randomized controlled trial. JAMA. 2005;293(24):3029–3035. doi: 10.1001/jama.293.24.3029. [DOI] [PubMed] [Google Scholar]
  • 92.van der Meer V, Knuistingh Neven A, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ. 2005;331(7507):26. doi: 10.1136/bmj.38483.478183.EB. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Little JW, Hall WJ, Douglas RG, Jr., Mudholkar GS, Speers DM, Patel K. Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis. 1978;118(2):295–303. doi: 10.1164/arrd.1978.118.2.295. [DOI] [PubMed] [Google Scholar]
  • 94.Fulmer JD, Snider GL. American College of Chest Physicians/National Heart, Lung, and Blood Institute National Conference on Oxygen Therapy. Heart Lung. 1984;13(5):550–562. [PubMed] [Google Scholar]
  • 95.Jeffrey AA, Warren PM, Flenley DC. Acute hypercapnic respiratory failure in patients with chronic obstructive lung disease: risk factors and use of guidelines for management. Thorax. 1992;47(1):34–40. doi: 10.1136/thx.47.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.http://www.brit-thoracic.org.uk/bts_guidelines_nippv_html.
  • 97.http://www.ics.ac.uk/downloads/icsstandards-levelsofca.pdf.
  • 98.Halm EA, Fine MJ, Kapoor WN, Singer DE, Marrie TJ, Siu AL. Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia. Arch Intern Med. 2002;162(11):1278–1284. doi: 10.1001/archinte.162.11.1278. [DOI] [PubMed] [Google Scholar]
  • 99.Hayden FG. Pandemic influenza: is an antiviral response realistic? Pediatr Infect Dis J. 2004;23(11 Suppl):S262–S269. doi: 10.1097/01.inf.0000144680.39895.ce. [DOI] [PubMed] [Google Scholar]
  • 100.Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere syndrome Trialists) States Group. Lancet. 1998;352(9144):1877–1881. [PubMed] [Google Scholar]
  • 101.Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet. 2000;355(9218):1845–1850. doi: 10.1016/s0140-6736(00)02288-1. [DOI] [PubMed] [Google Scholar]
  • 102.Jefferson T, Demicheli V, Deeks J, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev. 2000;(2):CD001265. doi: 10.1002/14651858.CD001265. [DOI] [PubMed] [Google Scholar]
  • 103.Whitley RJ, Hayden FG, Reisinger KS, Young N, Dutkowski R, Ipe D. Oral oseltamivir treatment of influenza in children. Pediatr Infect Dis J. 2001;20(2):127–133. doi: 10.1097/00006454-200102000-00002. [DOI] [PubMed] [Google Scholar]
  • 104.Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA. 1996;275(4):295–299. [PubMed] [Google Scholar]
  • 105.Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163(14):1667–1672. doi: 10.1001/archinte.163.14.1667. [DOI] [PubMed] [Google Scholar]
  • 106.Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG. Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob Agents Chemother. 2001;45(10):2723–2732. doi: 10.1128/AAC.45.10.2723-2732.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107.Galbraith AW, Oxford JS, Schild GC, Watson GI. Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment. Bull World Health Organ. 1969;41(3):677–682. [PMC free article] [PubMed] [Google Scholar]
  • 108.Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J Infect Dis. 2001;183(4):523–531. doi: 10.1086/318537. [DOI] [PubMed] [Google Scholar]
  • 109.Andrews J, Ashby J, Jevons G, Marshall T, Lines N, Wise R. A comparison of antimicrobial resistance rates in Gram-positive pathogens isolated in the UK from October 1996 to January 1997 and October 1997 to January 1998. J Antimicrob Chemother. 2000;45(3):285–293. doi: 10.1093/jac/45.3.285. [DOI] [PubMed] [Google Scholar]
  • 110.Wyllie DH, Peto TE, Crook D. MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997 2003. BMJ. 2005;331(7523):992. doi: 10.1136/bmj.38558.453310.8F. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Powell M, Yeo SF, Seymour A, Yuan M, Williams JD. Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J Antimicrob Chemother. 1992;29(5):547–554. doi: 10.1093/jac/29.5.547. [DOI] [PubMed] [Google Scholar]
  • 112.Felmingham D, Washington J. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens–findings of the Alexander Project 1992–1996. J Chemother. 1999;11(Suppl 1):5–21. doi: 10.1179/joc.1999.11.Supplement-2.5. [DOI] [PubMed] [Google Scholar]
  • 113.Johnson AP. Antibiotic resistance among clinically important gram-positive bacteria in the UK. J Hosp Infect. 1998;40(1):17–26. doi: 10.1016/s0195-6701(98)90020-2. [DOI] [PubMed] [Google Scholar]
  • 114.Zhanel GG, Ennis K, Vercaigne L, Walkty A, Gin AS, Embil J. A critical review of the fluoroquinolones: focus on respiratory infections. Drugs. 2002;62(1):13–59. doi: 10.2165/00003495-200262010-00002. [DOI] [PubMed] [Google Scholar]
  • 115.Firsov AA, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH. Antistaphylococcal effect related to the area under the curve/MIC ratio in an in vitro dynamic model: predicted breakpoints versus clinically achievable values for seven fluoroquinolones. Antimicrob Agents Chemother. 2005;49(7):2642–2647. doi: 10.1128/AAC.49.7.2642-2647.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.http://www.phac-aspc.gc.ca/cpip-pclcpi/.
  • 117.Meehan TP, Fine MJ, Krumholz HM, Scinto JD, Galusha DH, Mockalis JT. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278(23):2080–2084. [PubMed] [Google Scholar]
  • 118.Marrie TJ, Huang JQ. Community-acquired pneumonia in patients receiving home care. J Am Geriatr Soc. 2005;53(5):834–839. doi: 10.1111/j.1532-5415.2005.53264.x. [DOI] [PubMed] [Google Scholar]
  • 119.Fine MJ, Smith MA, Carson CA, Mutha SS, Sankey SS, Weissfeld LA. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275(2):134–141. [PubMed] [Google Scholar]
  • 120.Macfarlane J. Severe pneumonia and a second antibiotic. Lancet. 2002;359(9313):1170–1172. doi: 10.1016/S0140-6736(02)08250-8. [DOI] [PubMed] [Google Scholar]
  • 121.Moss PJ, Finch RG. The next generation: fluoroquinolones in the management of acute lower respiratory infection in adults. Thorax. 2000;55(1):83–85. doi: 10.1136/thorax.55.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Siegel RE, Alicea M, Lee A, Blaiklock R. Comparison of 7 versus 10 days of antibiotic therapy for hospitalized patients with uncomplicated community-acquired pneumonia: a prospective, randomized, double-blind study. Am J Ther. 1999;6(4):217–222. doi: 10.1097/00045391-199907000-00007. [DOI] [PubMed] [Google Scholar]
  • 123.Bonten MJ, Prins JM. Antibiotics in pandemic flu. BMJ. 2006;332(7536):248–249. doi: 10.1136/bmj.332.7536.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Peiris JS, Tang WH, Chan KH, Khong PL, Guan Y, Lau YL. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg Infect Dis. 2003;9(6):628–633. doi: 10.3201/eid0906.030009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Tran TH, Nguyen TL, Nguyen TD, Luong TS, Pham PM, Nguyen VC. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004;350(12):1179–1188. doi: 10.1056/NEJMoa040419. [DOI] [PubMed] [Google Scholar]
  • 126.Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351(9101):467–471. doi: 10.1016/s0140-6736(98)01182-9. [DOI] [PubMed] [Google Scholar]
  • 127.Cases of influenza A (H5N1) Thailand, 2004. MMWR Morb Mortal Wkly Rep. 2004;53(5):100–103. [PubMed] [Google Scholar]
  • 128.Swingler GH, Hussey GD, Zwarenstein M. Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children. Lancet. 1998;351(9100):404–408. doi: 10.1016/S0140-6736(97)07013-X. [DOI] [PubMed] [Google Scholar]
  • 129.Cherian T, Mulholland EK, Carlin JB, Ostensen H, Amin R, de Campo M. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005;83(5):353–359. [PMC free article] [PubMed] [Google Scholar]
  • 130.Davies HD, Wang EE, Manson D, Babyn P, Shuckett B. Reliability of the chest radiograph in the diagnosis of lower respiratory infections in young children. Pediatr Infect Dis J. 1996;15(7):600–604. doi: 10.1097/00006454-199607000-00008. [DOI] [PubMed] [Google Scholar]
  • 131.Korppi M, Kiekara O, Heiskanen-Kosma T, Soimakallio S. Comparison of radiological findings and microbial aetiology of childhood pneumonia. Acta Paediatr. 1993;82(4):360–363. doi: 10.1111/j.1651-2227.1993.tb12697.x. [DOI] [PubMed] [Google Scholar]
  • 132.Courtoy I, Lande AE, Turner RB. Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia. Clin Pediatr (Phila) 1989;28(6):261–264. doi: 10.1177/000992288902800604. [DOI] [PubMed] [Google Scholar]
  • 133.Clements H, Stephenson T, Gabriel V, Harrison T, Millar M, Smyth A. Rationalised prescribing for community acquired pneumonia: a closed loop audit. Arch Dis Child. 2000;83(4):320–324. doi: 10.1136/adc.83.4.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Meury S, Zeller S, Heininger U. Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents. Eur J Pediatr. 2004;163(7):359–363. doi: 10.1007/s00431-004-1445-6. [DOI] [PubMed] [Google Scholar]
  • 135.Navarro-Mari JM, Perez-Ruiz M, Cantudo-Munoz P, Petit-Gancedo C, Jimenez-Valera M, Rosa-Fraile M. Influenza-like illness criteria were poorly related to laboratory-confirmed influenza in a sentinel surveillance study. J Clin Epidemiol. 2005;58(3):275–279. doi: 10.1016/j.jclinepi.2004.08.014. [DOI] [PubMed] [Google Scholar]
  • 136.Esposito S, Marchisio P, Morelli P, Crovari P, Principi N. Effect of a rapid influenza diagnosis. Arch Dis Child. 2003;88(6):525–526. doi: 10.1136/adc.88.6.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Sharma V, Dowd MD, Slaughter AJ, Simon SD. Effect of rapid diagnosis of influenza virus type a on the emergency department management of febrile infants and toddlers. Arch Pediatr Adolesc Med. 2002;156(1):41–43. doi: 10.1001/archpedi.156.1.41. [DOI] [PubMed] [Google Scholar]
  • 138.Harnden A, Brueggemann A, Shepperd S, White J, Hayward AC, Zambon M. Near patient testing for influenza in children in primary care: comparison with laboratory test. BMJ. 2003;326(7387):480. doi: 10.1136/bmj.326.7387.480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Landry ML, Cohen S, Ferguson D. Comparison of Binax NOW and Directigen for rapid detection of influenza A and B. J Clin Virol. 2004;31(2):113–115. doi: 10.1016/j.jcv.2004.04.005. [DOI] [PubMed] [Google Scholar]
  • 140.Rawlinson WD, Waliuzzaman ZM, Fennell M, Appleman JR, Shimasaki CD, Carter IW. New point of care test is highly specific but less sensitive for influenza virus A and B in children and adults. J Med Virol. 2004;74(1):127–131. doi: 10.1002/jmv.20155. [DOI] [PubMed] [Google Scholar]
  • 141.Kim PE, Musher DM, Glezen WP, Rodriguez-Barradas MC, Nahm WK, Wright CE. Association of invasive pneumo-coccal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis. 1996;22(1):100–106. doi: 10.1093/clinids/22.1.100. [DOI] [PubMed] [Google Scholar]
  • 142.Thomas P, Riffelmann M, Schweiger B, Dominik S, von Konig CH. Fatal influenza A virus infection in a child vaccinated against influenza. Pediatr Infect Dis J. 2003;22(2):201–202. [PubMed] [Google Scholar]
  • 143.MacDonald KL, Osterholm MT, Hedberg CW, Schrock CG, Peterson GF, Jentzen JM. Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA. 1987;257(8):1053–1058. doi: 10.1001/jama.257.8.1053. [DOI] [PubMed] [Google Scholar]
  • 144.Connor E, Powell K. Fulminant pneumonia caused by concomitant infection with influenza B virus and Staphylococcus aureus. J Pediatr. 1985;106(3):447–450. doi: 10.1016/s0022-3476(85)80676-4. [DOI] [PubMed] [Google Scholar]
  • 145.Takala AK, Meurman O, Kleemola M, Kela E, Ronnberg PR, Eskola J. Preceding respiratory infection predisposing for primary and secondary invasive Haemophilus influenzae type b disease. Pediatr Infect Dis J. 1993;12(3):189–195. doi: 10.1097/00006454-199303000-00003. [DOI] [PubMed] [Google Scholar]
  • 146.Navarro D, Garcia-Maset L, Gimeno C, Escribano A, Garcia-de-Lomas J. Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection. J Clin Microbiol. 2004;42(10):4853–4855. doi: 10.1128/JCM.42.10.4853-4855.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 147.Esposito S, Bosis S, Colombo R, Carlucci P, Faelli N, Fossali E. Evaluation of rapid assay for detection of Streptococcus pneumoniae urinary antigen among infants and young children with possible invasive pneumococcal disease. Pediatr Infect Dis J. 2004;23(4):365–367. doi: 10.1097/00006454-200404000-00021. [DOI] [PubMed] [Google Scholar]
  • 148.Heaton P, Arthur K. The utility of chest radiography in the follow-up of pneumonia. NZ Med J. 1998;111(1072):315–317. [PubMed] [Google Scholar]
  • 149.Gibson NA, Hollman AS, Paton JY. Value of radiological follow up of childhood pneumonia. BMJ. 1993;307(6912):1117. doi: 10.1136/bmj.307.6912.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 150.Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004;363(9409):617. doi: 10.1016/S0140-6736(04)15595-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Hayden FG, Sperber SJ, Belshe RB, Clover RD, Hay AJ, Pyke S. Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine. Antimicrob Agents Chemother. 1991;35(9):1741–1747. doi: 10.1128/aac.35.9.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 152.Shiraishi K, Mitamura K, Sakai-Tagawa Y, Goto H, Sugaya N, Kawaoka Y. High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis. 2003;188(1):57–61. doi: 10.1086/375799. [DOI] [PubMed] [Google Scholar]
  • 153.Hayden FG, Belshe RB, Clover RD, Hay AJ, Oakes MG, Soo W. Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. N Engl J Med. 1989;321(25):1696–1702. doi: 10.1056/NEJM198912213212502. [DOI] [PubMed] [Google Scholar]
  • 154.Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner D, Nicholson KG. Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BMJ. 2003;326(7401):1235. doi: 10.1136/bmj.326.7401.1235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Matheson NJ, Symmonds-Abrahams M, Sheikh A, Shepperd S, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database Syst Rev. 2003;(3):CD002744. doi: 10.1002/14651858.CD002744. [DOI] [PubMed] [Google Scholar]
  • 156.Johnston SL, Ferrero F, Garcia ML, Dutkowski R. Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma. Pediatr Infect Dis J. 2005;24(3):225–232. doi: 10.1097/01.inf.0000154322.38267.ce. [DOI] [PubMed] [Google Scholar]
  • 157.Oo C, Hill G, Dorr A, Liu B, Boellner S, Ward P. Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1 5 years. Eur J Clin Pharmacol. 2003;59(5–6):411–415. doi: 10.1007/s00228-003-0639-6. [DOI] [PubMed] [Google Scholar]
  • 158.Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004;364(9436):759–765. doi: 10.1016/S0140-6736(04)16934-1. [DOI] [PubMed] [Google Scholar]
  • 159.Neuzil KM, Zhu Y, Griffin MR, Edwards KM, Thompson JM, Tollefson SJ. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002;185(2):147–152. doi: 10.1086/338363. [DOI] [PubMed] [Google Scholar]
  • 160.Okamoto S, Kamiya I, Kishida K, Shimakawa T, Fukui T, Morimoto T. Experience with oseltamivir for infants younger than 1 year old in Japan. Pediatr Infect Dis J. 2005;24(6):575–576. doi: 10.1097/01.inf.0000164799.33635.fe. [DOI] [PubMed] [Google Scholar]
  • 161.Tamura D, Miura T, Kikuchi Y. Oseltamivir phosphate in infants under 1 year of age with influenza infection. Pediatr Int. 2005;47(4):484. doi: 10.1111/j.1442-200x.2005.02088.x. [DOI] [PubMed] [Google Scholar]
  • 162.Rodriguez WJ, Hall CB, Welliver R, Simoes EA, Ryan ME, Stutman H. Efficacy and safety of aerosolized ribavirin in young children hospitalized with influenza: a double-blind, multicenter, placebo-controlled trial. J Pediatr. 1994;125(1):129–135. doi: 10.1016/s0022-3476(94)70139-3. [DOI] [PubMed] [Google Scholar]
  • 163.Maeda S, Yamada Y, Nakamura H, Maeda T. Efficacy of antibiotics against influenza-like illness in an influenza epidemic. Pediatr Int. 1999;41(3):274–276. doi: 10.1046/j.1442-200x.1999.01069.x. [DOI] [PubMed] [Google Scholar]
  • 164.Ninomiya K, Fukui T, Imai T, Matsui M, Matsuoka K. Effect of maclorides on duration and resolution of symptoms and complication of pneumonia in children with influenza. J Nippon Med Sch. 2002;69(1):53–57. doi: 10.1272/jnms.69.53. [DOI] [PubMed] [Google Scholar]
  • 165.Atkinson M, Lorgelli P, Lakhanpaul M, Smyth A, Vyas H, Weston V. A randomised controlled equilanence trial to compare oral and intravenous treatment and the direct and indirect costs of treating children with community acquired pneumonia: PIVOT trial. Arch Dis Child. 2005;90(Suppl ii):A87. [Google Scholar]
  • 166.Claas EC, Osterhaus AD, van Beek R, de Jong JC, Rimmelzwaan GF, Senne DA. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998;351(9101):472–477. doi: 10.1016/S0140-6736(97)11212-0. [DOI] [PubMed] [Google Scholar]
  • 167.Chan PK. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002;34(Suppl 2):S58–S64. doi: 10.1086/338820. [DOI] [PubMed] [Google Scholar]
  • 168.http://www.who.int/csr/disease/avian_influenza/country/en/index.html.
  • 169.Hien TT, de Jong M, Farrar J. Avian influenza a challenge to global health care structures. N Engl J Med. 2004;351(23):2363. doi: 10.1056/NEJMp048267. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Infection are provided here courtesy of Elsevier

RESOURCES